This report shows public data only. Is this your organisation? If so, login here to view your full report.

Trecento

PRI reporting framework 2020

serch-btn
Organisational Overview
Basic information [OO 01 - 09] Asset class implementation gateway indicators [OO 10 - 12] Peering questions [OO LE 01 - HF 01]
Strategy and Governance
Investment policy [SG 01 - 04] Objectives and strategies [SG 05 - 06] Governance and human resources [SG 07 - 08] Promoting responsible investment [SG 09 - 11] Outsourcing to fiduciary managers and investment consultants [SG 12] ESG issues in asset allocation [SG 13 - 15] Innovation [SG 18] Communication [SG 19]
Direct - Listed Equity Incorporation
ESG incorporation in actively managed listed equities [LEI 01 - 10] Implementation processes [LEI 01 - 10] (A) Implementation: Screening [LEI 04 - 06] (B) Implementation: Thematic [LEI 07] (C) Implementation: Integration of ESG factors [LEI 08 - 10] Outputs and outcomes [LEI 12 - 13]
Direct - Listed Equity Active Ownership
Overview [LEA 01] Engagement [LEA 02 - 08] Outputs and outcomes [LEA 09 - 11] (Proxy) voting and shareholder resolutions [LEA 12 - 21]
Direct - Fixed Income
ESG incorporation in actively managed fixed income [FI 01 - 12] Implementation processes [FI 01 - 03] (A) Implementation: Screening [FI 04 - 06] (B) Implementation: Thematic [FI 07 - 09] (C) Implementation: Integration [FI 10 - 12] Fixed income - Engagement [FI 14 - 16] Outputs and outcomes [FI 17 - 18]
Direct – Private Equity
Overview [PE 01 - 02] Fundraising of private equity funds [PE 03 - 04] Pre-investment (selection) [PE 05 - 08] Post-investment (monitoring) [PE 09 - 13] Outputs and outcomes [PE 14 - 15] Communication [PE 16]
Confidence building measures
Confidence building measures [CM1 01 - 07]
Export Public Responses
Pdf-img

You are in Direct - Listed Equity Active Ownership » Outputs and outcomes

Outputs and outcomes

LEA 09. Number of companies engaged with, intensity of engagement and effort

Indicate the proportion of companies in your listed equities portfolio with which your organisation engaged during the reporting year.
We did not complete any engagements in the reporting year.

Number of companies engaged

(avoid double counting, see explanatory notes)
Proportion of companies engaged with, out of total listed equities portfolio

Individual / Internal staff engagements

38
35

09.2. Indicate the breakdown of engagements conducted within the reporting year by the number of interactions (including interactions made on your behalf).

No. of interactions with a company
% of engagements
One interaction
2 to 3 interactions
More than 3 interactions
Total
100%

09.5. Additional information. [Optional]

LEA 10. Engagement methods

10.1. Indicate which of the following your engagement involved.

10.2. Additional information. [Optional]

All the information regarding engagement is recorded, stored on the company network and made available to all in order to be used by analysts and fund managers in investment decision-making.

LEA 11. Examples of ESG engagements

11.1. Provide examples of the engagements that your organisation or your service provider carried out during the reporting year.

ESG Topic
Executive Remuneration|General ESG|Diversity|Sustainability reporting|Cyber security
Conducted by
Objectives

We engaged with an issuer on its global ESG policy and to discuss specific issues. Our objectives were to get answers on specific ESG issues raised before the meeting.
Scope and Process

The dialogue with the issuer was quite broad and allowed us to get a deeper understanding of the overall ESG and CSR strategy of the issuer. The main focus of discussion was on the criteria selected for the executive remuneration (and their appropriateness), the efforts of the company to increase the gender diversity, the evolution of the governance and the composition of the audit committee. Some points could be answered (when asked about the percentage of the consumed electricity coming from renewable sources for example) but the issuer committed to improve its transparency and the depth of its ESG/CSR reporting.
Outcomes
ESG Topic
Diversity|Other

specify
Conducted by
Objectives

Encourage the issuer to increase the gender diversity of its board of directors and top management.

Discuss the issuer's policy regarding access to medicines
Scope and Process

We adressed the gender diversity first because we were concerned about the relatively low percentage of women in the board of directors and top management. The issuer acknowledged its difficulties in increasing the gender diversity but confirm that they are diligently trying to and had made recent appointments.

Regarding the access to medecine, especially for low income patients or emerging markets, the issuer explained they have implemented specific policies, either linking drug prices to purchasing power parity or encouraging the expansion of their generic division.
Outcomes
ESG Topic
Health and Safety|Labour practices and supply chain management
Conducted by
Objectives

Follow up on a controversy linked to understaffed medical retirement homes
Scope and Process

The company acknowledged that some retirement homes had difficulties to recruit staff but denied that patients' health and safety were put at risk. The company committed to a significant hiring process to increase the number of staff per patient.
Outcomes

11.2. Additional information. [Optional]

Previous Section Next Section
Top